Eli Lilly (LLY) Accumulated Depreciation & Amortization (2016 - 2025)
Historic Accumulated Depreciation & Amortization for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.
- Eli Lilly's Accumulated Depreciation & Amortization rose 1010.3% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 1010.3%. This contributed to the annual value of $1.8 billion for FY2024, which is 1566.82% up from last year.
- As of Q3 2025, Eli Lilly's Accumulated Depreciation & Amortization stood at $1.4 billion, which was up 1010.3% from $941.3 million recorded in Q2 2025.
- Eli Lilly's Accumulated Depreciation & Amortization's 5-year high stood at $1.8 billion during Q4 2024, with a 5-year trough of $350.3 million in Q1 2021.
- In the last 5 years, Eli Lilly's Accumulated Depreciation & Amortization had a median value of $941.3 million in 2025 and averaged $970.9 million.
- Per our database at Business Quant, Eli Lilly's Accumulated Depreciation & Amortization soared by 2803.36% in 2021 and then tumbled by 1684.65% in 2023.
- Quarter analysis of 5 years shows Eli Lilly's Accumulated Depreciation & Amortization stood at $1.5 billion in 2021, then fell by 1.62% to $1.5 billion in 2022, then grew by 0.32% to $1.5 billion in 2023, then rose by 15.67% to $1.8 billion in 2024, then decreased by 20.11% to $1.4 billion in 2025.
- Its Accumulated Depreciation & Amortization stands at $1.4 billion for Q3 2025, versus $941.3 million for Q2 2025 and $462.8 million for Q1 2025.